| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_291f56b4a35097fb62c086ba2d72caf7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1994-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8144e2dedde15118d3a3729643137484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0d43789a18cb38f48cc250b6eaaa25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_847689d95ae37c5930852361b25135ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23b460e053f99cf4417275f061da4947
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd18c6d2ec601e1b496c76862234f946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208d9979deefe3d399e8d3cf7b90bead |
| publicationDate |
1995-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9503810-A1 |
| titleOfInvention |
Use of esculentoside a for treatment of lipopolysaccharide and macrophage mediated disorders |
| abstract |
Esculentoside A is incorporated into pharmaceutical compositions and used for treating patients to modulate biological response. In particular, biological responses such as lipopolysaccharide induction of nitric oxide and macrophage activation are inhibited in order to treat a variety of disease conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1811839-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1811839-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9833379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109432111-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6160021-A |
| priorityDate |
1993-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |